Dianhydrogalactitol (NSC-132313): Phase II study in solid tumors-Reference-Cited by-同舟云学术

Dianhydrogalactitol (NSC-132313): Phase II study in solid tumors

Author:

De Jager R.,Brugarolas A.,Hansen H.,Cavalli F.,Ryssel H.,Siegenthaler P.,Clarysse A.,Renard J.,Kenis Y.,Alberto P.

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Metabolic pathway of cytostatic dibromohexitols;Institoris;Cancer Treat. Rep.,1967

2. Pharmacologic and antitumor effect of 1,2:5,6-dianhydrogalactitol (NSC-132313);Németh;Cancer Chemother. Rep.,1972

3. A mouse ependymoblastoma as an experimental model for screening potential anti-neoplastic drugs;Geran;Cancer Chemother. Rep.,1974

4. Uptake of labeled dianhydrogalactitol into human gliomas and nervous tissue;Eckhardt;Cancer Treat. Rep.,1977

5. Phase I trial of dianhydrogalactitol administered i.v. in a weekly schedule;Vogel;Cancer Treat. Rep.,1976

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. New EORTC compounds;Cancer Treatment Reviews;1990-09

3. Microsynthesis of Dianhydrohexitols;Journal of Carbohydrate Chemistry;1989-03

4. Systemic chemotherapy of transitional cell carcinoma of the urothelium;Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances;1989